US Patent Issued to NewBio Therapeutics on Jan. 28 for "Anti-CD79b antibodies, drug conjugates, and applications thereof" (Chinese Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,289, issued on Jan. 28, was assigned to NewBio Therapeutics Inc. (Shanghai).

"Anti-CD79b antibodies, drug conjugates, and applications thereof" was invented by Nianhe Han (Shanghai), Liwei Song (Shanghai), Deqiang An (Shanghai), Di Zeng (Shanghai), Huali Li (Shanghai) and Chun Yang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is an anti-CD79b antibody or antigen-binding fragment thereof, a drug conjugate thereof and use thereof. The anti-CD79b antibody or antigen-binding fragment thereof herein comprises: HCDR1 comprising the amino acid sequence of SEQ ID NO: 1; HCDR2 comprising the amino acid sequence of SEQ ID NO: 2; H...